Cargando…
Relapsed plasmablastic lymphoma in a HIV‐negative patient: Pushing the envelope
This case emphasizes that, with the availability of novel immunotherapy agents (Daratumumab), and repurposed use of bortezomib, a patient with HIV‐negative relapsed PBL can be treated successfully and consolidated with an allogeneic haploidentical hematopoietic cell transplantation.
Autores principales: | Kathrotiya, Manthan, Radhakrishnan, Vivek S, Bhave, Saurabh J, Kumar, Jeevan, Roychowdhury, Mita, Arun, Indu, Das, Jayanta, Chandy, Mammen, Nair, Reena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869339/ https://www.ncbi.nlm.nih.gov/pubmed/33598263 http://dx.doi.org/10.1002/ccr3.3673 |
Ejemplares similares
-
Impact of COVID-19 on peripheral stem cell collection and preservation at a hematopoietic cell transplant center in India: Experience 2020
por: Javed, Rizwan, et al.
Publicado: (2021) -
Relapsed Refractory Hodgkin Lymphoma and Brentuximab Vedotin-Bendamustine Combination Therapy as a Bridge to Transplantation: Real-World Evidence From a Middle-Income Setting and Literature Review
por: Radhakrishnan, Vivek S., et al.
Publicado: (2022) -
Outcomes of diffuse large B-cell lymphoma in elderly patients—real-world experience from a middle-income country setting
por: Sarker, Chandrayee, et al.
Publicado: (2021) -
PB2223: CLINICOPATHOLOGICAL, CYTOGENETIC AND MOLECULAR CHARACTERISTICS OF PATIENTS WITH NON-CML MYELOPROLIFERATIVE NEOPLASMS: A SINGLE CENTER STUDY
por: Guntiboina, Vinay Anand, et al.
Publicado: (2023) -
Should we adopt an automated de-centralized model of chimeric antigen receptor- T cells manufacturing for low-and middle-income countries? A real world perspective
por: Ramakrishnan, Sharanya, et al.
Publicado: (2022)